Alissa Brandes

931 total citations
8 papers, 317 citations indexed

About

Alissa Brandes is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alissa Brandes has authored 8 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alissa Brandes's work include CAR-T cell therapy research (2 papers), Enzyme Structure and Function (2 papers) and Adenosine and Purinergic Signaling (1 paper). Alissa Brandes is often cited by papers focused on CAR-T cell therapy research (2 papers), Enzyme Structure and Function (2 papers) and Adenosine and Purinergic Signaling (1 paper). Alissa Brandes collaborates with scholars based in United States and Germany. Alissa Brandes's co-authors include Christopher Ward, Sabrina M. Ronen, David A. Scheinberg, Carlos H. Villa, Hagit Dafni, C. David James, Danica Chiu, Daphne A. Haas-Kogan, Yue‐Ming Li and John Kurhanewicz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Alissa Brandes

8 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alissa Brandes United States	6	148	99	98	93	36	8	317
Murali Cherukuri United States	8	126 0.9×	111 1.1×	123 1.3×	119 1.3×	13 0.4×	14	372
Laura Guidoni Italy	12	199 1.3×	43 0.4×	79 0.8×	78 0.8×	19 0.5×	27	336
Edna Rushkin Israel	9	224 1.5×	93 0.9×	211 2.2×	124 1.3×	18 0.5×	10	462
Walter A. Ausserer United States	13	273 1.8×	68 0.7×	113 1.2×	174 1.9×	36 1.0×	18	590
Siobhan Donnelly United States	7	159 1.1×	43 0.4×	143 1.5×	55 0.6×	9 0.3×	7	354
Wanda B. Mackinnon Australia	13	306 2.1×	107 1.1×	216 2.2×	63 0.7×	25 0.7×	16	534
Georgios Batsios United States	11	99 0.7×	81 0.8×	99 1.0×	67 0.7×	29 0.8×	23	271
Teresa Delgado‐Goñi Spain	11	166 1.1×	27 0.3×	88 0.9×	90 1.0×	9 0.3×	16	341
Nada M.S. Al-Saffar United Kingdom	11	373 2.5×	201 2.0×	303 3.1×	213 2.3×	21 0.6×	13	700
Kshama Natarajan United States	11	200 1.4×	36 0.4×	190 1.9×	123 1.3×	11 0.3×	16	478

Countries citing papers authored by Alissa Brandes

Since Specialization

Citations

This map shows the geographic impact of Alissa Brandes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alissa Brandes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alissa Brandes more than expected).

Fields of papers citing papers by Alissa Brandes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alissa Brandes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alissa Brandes. The network helps show where Alissa Brandes may publish in the future.

Co-authorship network of co-authors of Alissa Brandes

This figure shows the co-authorship network connecting the top 25 collaborators of Alissa Brandes. A scholar is included among the top collaborators of Alissa Brandes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alissa Brandes. Alissa Brandes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Brandes, Alissa, A. Koo, Kathryn Michels, et al.. (2024). Nonclinical Toxicology, Biodistribution, and Pharmacokinetics of UB-VV111, an In Vivo Anti-CD19 CAR T Cell Therapy. Blood. 144(Supplement 1). 2046–2046. 1 indexed citations

Brandes, Alissa, Susana Hernández, Christopher J. Nicolai, et al.. (2023). 438 In vivo Engineered CAR-T cells for oncology using a surface-engineered lentivirus platform: nonclinical safety and biodistribution. SHILAP Revista de lepidopterología. A487–A487. 1 indexed citations

Burstein, Suzanne R., Alissa Brandes, Li Chin Wong, et al.. (2020). Preclinical development of PR006, a gene therapy for the treatment of frontotemporal dementia with progranulin mutations. Alzheimer s & Dementia. 16(S2). 5 indexed citations

Chiu, Danica, Alissa Brandes, Freddy E. Escorcia, et al.. (2014). Nontranscriptional Role of Hif-1α in Activation of γ-Secretase and Notch Signaling in Breast Cancer. Cell Reports. 8(4). 1077–1092. 103 indexed citations

Ward, Christopher, Pia Eriksson, José Luis Izquierdo-García, Alissa Brandes, & Sabrina M. Ronen. (2013). HDAC Inhibition Induces Increased Choline Uptake and Elevated Phosphocholine Levels in MCF7 Breast Cancer Cells. PLoS ONE. 8(4). e62610–e62610. 32 indexed citations

Brandes, Alissa, Christopher Ward, & Sabrina M. Ronen. (2010). 17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2. Breast Cancer Research. 12(5). R84–R84. 28 indexed citations

Ward, Christopher, Humsa S. Venkatesh, Myriam M. Chaumeil, et al.. (2010). Noninvasive Detection of Target Modulation following Phosphatidylinositol 3-Kinase Inhibition Using Hyperpolarized 13C Magnetic Resonance Spectroscopy. Cancer Research. 70(4). 1296–1305. 119 indexed citations

Ullrich, D., et al.. (1992). Urinary caffeine metabolites in man. European Journal of Clinical Pharmacology. 43(2). 167–172. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact